Raffaele Costanzo Selected Research

Raffaele Costanzo Research Topics

Disease

15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 02/2008
8	Neoplasms (Cancer) 02/2021 - 03/2014
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 08/2014
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2006
2	Disease Progression 01/2022 - 07/2013
2	Adenocarcinoma of Lung 01/2022 - 05/2013
2	Circulating Neoplastic Cells 01/2022 - 11/2012
2	Lung Neoplasms (Lung Cancer) 07/2020 - 10/2019
2	Fatigue 01/2018 - 04/2010
2	Adenocarcinoma 09/2017 - 01/2016
1	Necrosis 02/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Anorexia 01/2018
1	Diarrhea 01/2016
1	Hemorrhage 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Carcinoma (Carcinomatosis) 08/2014
1	Neutropenia 02/2008
1	Vomiting 02/2008
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2005
1	Muscular Dystrophies (Muscular Dystrophy) 03/2005
1	Cardiac Arrhythmias (Arrythmia) 03/2005
1	Familial primary gastric lymphoma 03/2005
1	Cardiotoxicity 03/2005
1	Atrial Fibrillation 03/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2004
1	Lymphoma (Lymphomas) 07/2004

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 09/2020 - 07/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 07/2013
4	Gemcitabine FDA Link 03/2014 - 02/2008
4	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2014 - 01/2011
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
2	pembrolizumabIBA 09/2020 - 10/2019
2	Docetaxel (Taxotere)FDA Link 09/2017 - 01/2016
2	nintedanibIBA 09/2017 - 01/2016
2	EnzymesIBA 01/2016 - 04/2010
2	Pemetrexed (MTA)FDA Link 03/2014 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2010 - 02/2008
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	NivolumabIBA 09/2020
1	Monoclonal AntibodiesIBA 07/2020
1	atezolizumabIBA 07/2020
1	B7-H1 AntigenIBA 10/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	AfatinibIBA 01/2016
1	CreatinineIBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Cystatin CIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 08/2014
1	Bevacizumab (Avastin)FDA Link 01/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013
1	Keratin-7 (Cytokeratin 7)IBA 05/2013
1	Cetuximab (Erbitux)FDA Link 02/2012
1	liposomal doxorubicin (Doxil)FDA Link 01/2006
1	Temozolomide (Temodar)FDA LinkGeneric 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2005
1	Rituximab (Mabthera)FDA Link 07/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2004

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 07/2020 - 07/2004
4	Therapeutics 01/2022 - 07/2013
1	General Anesthesia 02/2021
1	Palliative Care (Palliative Therapy) 02/2021
1	Mastectomy (Mammectomy) 02/2021
1	Segmental Mastectomy (Lumpectomy) 02/2021
1	Radical Mastectomy 02/2021
1	Immunotherapy 09/2020
1	Radiotherapy 01/2017